Search Results - Erlich, Elyse

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women

    Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women by Freemantle, N., Satram-Hoang, S., Tang, E.-T., Kaur, P., Macarios, D., Siddhanti, S., Borenstein, J., Kendler, D. L.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Adherence, preference, and satisfaction of postmenopausal women taking denosumab or alendronate

    Adherence, preference, and satisfaction of postmenopausal women taking denosumab or alendronate by Kendler, D. L., McClung, M. R., Freemantle, N., Lillestol, M., Moffett, A. H., Borenstein, J., Satram-Hoang, S., Yang, Y.-C., Kaur, P., Macarios, D., Siddhanti, S.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Paclitaxel Is Only a Weak Radiosensitizer of Human Cervical Carcinoma Cell Lines

    Paclitaxel Is Only a Weak Radiosensitizer of Human Cervical Carcinoma Cell Lines by Erlich, Elyse, McCall, Anne R., Potkul, R.K., Walter, Scott, Vaughan, Andrew

    Published in Gynecologic oncology
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: